Cloonan Michael

US insider· US
Sign in for alerts
  • ACQUIREDT+30

    Sionna Therapeutics Inc · NASDAQ

    +109,025 sh

    Filed 18 Sept 2026SEC Form 4view source
  • ACQUIREDT+30

    Sionna Therapeutics Inc · NASDAQ

    +109,025 sh

    Filed 18 Sept 2026SEC Form 4view source